NASDAQ: LPTX       Leap Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
2.56   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):318,652
4 Weeks Range:1.99 - 2.59
4 Weeks Price Volatility (%):
52 Weeks Range:0.57 - 3.18
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Leap Therapeutics Inc is a biopharmaceutical company. The company is acquiring and developing novel therapeutics at the leading edge of cancer biology. Its programs are monoclonal antibodies that target key cellular pathways that enable cancer to grow and spread and specific mechanisms that activate the body's immune system to identify and attack cancer. Leap has two clinical stage programs: DKN-01 and TRX518. DKN-01 is a monoclonal antibody targeting Dickkopf-related protein 1, or DKK1, a protein that regulates important cell signaling pathways, known as the Wnt pathways. TRX518 is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor, or GITR, a receptor found on the surface of a wide range of immune cells.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor


Top 10 Active Counters
 HIPS 11.8390.00 
 HONE 7.930.00 
 ENZL 52.460.00 
 KOD 64.220.00 
 UPRO 43.540.00 
 COLD 35.760.00 
 ALYA 1.770.00 
 CIGI 52.110.00 
 AXNX 36.880.00 
 PQLC 50.0030.00 
Partners & Brokers